The University of Oxford in partnership with AstraZeneca began vaccinations on 27 June 2021 for a new phase in human trials to test a COVID-19 vaccine ‘AZD2816’ in volunteers against the B.1.351 variant of concern – commonly known as the Beta variant. The Phase II/III trial, sponsored and led by AstraZeneca will recruit approximately 2,250 […]
Oxford University Hospitals (OUH) has made a grant of £11.5 million to the University of Oxford, which the University will match with other funding, to allow the development of major clinical research facilities which have the potential to support the introduction of innovative and ground-breaking treatments for patients. Oxford is one of the most vibrant […]
Researchers at Oxford Brookes University have been awarded funding to improve bus shelter design, to counteract roadside traffic pollution. The project is part of the University of Birmingham-led TRANSITION Clean Air Network, which is funding five new research projects aimed at improving air quality by reducing harmful transport emissions. Oxford Brookes University researchers led by Dr Fabrizio Bonatesta, Reader […]
A research team, involving academics at Oxford Brookes University, has been awarded a share of a £1.6 million grant from UK Research and Innovation (UKRI) to develop smart shoe insoles to help tackle diabetic foot ulcers. Diabetic foot ulcers affect a quarter of people with diabetes and cost the NHS around £1 billion a year. Funded by UKRI’s Engineering and […]
A dedicated Psychological Medicine Staff Support Service has been created to support staff working at Oxford University Hospitals (OUH) – thanks to the support of NHS Charities Together. Oxford Hospitals Charity was successful in bidding for £150,000 from NHS Charities Together to fund two clinical psychologist roles and one part time clinical psychiatrist who will […]
Additional inpatient ward space is now open for patients at the John Radcliffe Hospital. Ward 5E/F is an Acute Medical Short Stay Ward, located on level 5 of the hospital, providing a bright, open, and spacious environment for patients who are due to spend a short time in hospital. The ward has 24 additional beds across […]
The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own. The treatment uses a combination of two monoclonal antibodies (casirivimab and imdevimab, known […]
A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia. Strikingly, these individuals were twice as likely to report that they were COVID-19 vaccine hesitant – that is, they would put off getting vaccinated or indeed never get the jab. The study indicates that if […]
Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population. While this is expected to improve with the second dose, this important finding may help influence the design of future vaccination strategies, with further […]
The 2021 G7 Health Ministers’ Meeting will be held in-person in Oxford on 3-4 June and will bring together health leaders from the world’s leading democracies to agree life-saving action in critical areas of global health. They will convene at Oxford University, which has been at the heart of the global fight against COVID-19, with world-leading […]